What's new

Payers Continue Attempts to Restrict Lucentis and Eylea
Dec 17, 2014    Advocacy & Practice Updates
FDA Grants Breakthrough Therapy Designation to Lucentis for Diabetic Retinopathy
Dec 17, 2014    Industry News
New Research Shows Potential Benefits of HIV Treatment for Dry-AMD Patients
Dec 15, 2014    Clinical Updates
December Featured Surgical Video: Explantation of a Dislocated IOL and Secondary Scleral Fixation of Akreos Lens
Dec 10, 2014    Clinical Updates
ASRS Writes Letter to MedPAC on Potential New Payment Policies That Could Affect Retina Specialists
Dec 10, 2014    Advocacy & Practice Updates
UHC’s 2015 Premium Physician Designation Program Assessments Are Rolling Out
Dec 3, 2014    Advocacy & Practice Updates
Medicare Increases PQRS Payment Penalties for 2015 Performance
Nov 26, 2014    Advocacy & Practice Updates
2015 MPFS Final Rule Cuts Payments to Retina Specialists
Nov 26, 2014    Advocacy & Practice Updates

Retina Times

Fall 2014, Vol. 32, No. 4, Iss. 56

In this issue:

ASRS 32nd Annual Meeting Highlights
ASRS 32nd Annual Meeting Draws 1798—a 15% Increase Over Last Year’s Record Attendance

International Corner/Retinomics
First Global Trends in Retina Survey Explores Practice Patterns -- PART 1: MEDICAL RETINA HIGHLIGHTS

 Retinomics Perspectives
‘Narrow Network’ Plans on the ACA’s Insurance Exchange May Restrict Access to Retina Specialists

Research & Development
PART 3 IN A SERIES: Considering the Long-Term Effects of Anti-VEGF Treatment

Part 2 of 2: How Will Health System Changes Affect Your Practice?

Block Time
SCORE2 Compares Avastin, Eylea for CRVO

Read all articles »


17th Annual Practice Management Issues Seminar
March 28-29, 2015
Dallas, Texas

ASRS 33rd Annual Meeting
July 11-14, 2015
Vienna, Austria